Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 1 as of June 8, 2020.
Flisiak R, Horban A, Jaroszewicz J, Kozielewicz D, Pawłowska M, Parczewski M, Piekarska A, Simon K, Tomasiewicz K, Zarębska-Michaluk D. Flisiak R, et al. Among authors: horban a. Pol Arch Intern Med. 2020 Jun 25;130(6):557-558. doi: 10.20452/pamw.15424. Epub 2020 Jun 8. Pol Arch Intern Med. 2020. PMID: 32529822 Free article. No abstract available.
The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.
Flisiak R, Horban A, Gallay P, Bobardt M, Selvarajah S, Wiercinska-Drapalo A, Siwak E, Cielniak I, Higersberger J, Kierkus J, Aeschlimann C, Grosgurin P, Nicolas-Métral V, Dumont JM, Porchet H, Crabbé R, Scalfaro P. Flisiak R, et al. Among authors: horban a. Hepatology. 2008 Mar;47(3):817-26. doi: 10.1002/hep.22131. Hepatology. 2008. PMID: 18302285 Clinical Trial.
Prevalence and risk factors of HCV infection in Poland.
Flisiak R, Halota W, Horban A, Juszczyk J, Pawlowska M, Simon K. Flisiak R, et al. Among authors: horban a. Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1213-7. doi: 10.1097/MEG.0b013e32834d173c. Eur J Gastroenterol Hepatol. 2011. PMID: 22002000
Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.
Parczewski M, Siwak E, Leszczyszyn-Pynka M, Cielniak I, Burkacka E, Pulik P, Witor A, Muller K, Zasik E, Grzeszczuk A, Jankowska M, Lemańska M, Olczak A, Grąbczewska E, Szymczak A, Gąsiorowski J, Szetela B, Bociąga-Jasik M, Skwara P, Witak-Jędra M, Jabłonowska E, Wójcik-Cichy K, Kamerys J, Janczarek M, Krankowska D, Mikuła T, Kozieł K, Bielec D, Stempkowska J, Kocbach A, Błudzin W, Horban A. Parczewski M, et al. Among authors: horban a. J Int AIDS Soc. 2017 Jul 17;20(1):21847. doi: 10.7448/IAS.20.1.21847. J Int AIDS Soc. 2017. PMID: 28715160 Free PMC article.
Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study.
Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K. Flisiak R, et al. Among authors: horban a. Clin Exp Hepatol. 2016 Dec;2(4):138-143. doi: 10.5114/ceh.2016.63870. Epub 2016 Nov 28. Clin Exp Hepatol. 2016. PMID: 28856278 Free PMC article.
Prevalence of HCV genotypes in Poland - the EpiTer study.
Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K. Flisiak R, et al. Among authors: horban a. Clin Exp Hepatol. 2016 Dec;2(4):144-148. doi: 10.5114/ceh.2016.63871. Epub 2016 Nov 28. Clin Exp Hepatol. 2016. PMID: 28856279 Free PMC article.
Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?
Zarębska-Michaluk D, Flisiak R, Jaroszewicz J, Janczewska E, Czauż-Andrzejuk A, Berak H, Horban A, Staniaszek A, Gietka A, Tudrujek M, Tomasiewicz K, Dybowska D, Halota W, Piekarska A, Sitko M, Garlicki A, Orłowska I, Simon K, Belica-Wdowik T, Baka-Ćwierz B, Mazur W, Białkowska J, Socha Ł, Wawrzynowicz-Syczewska M, Laurans Ł, Deroń Z, Lorenc B, Dobracka B, Tronina O, Pawłowska M. Zarębska-Michaluk D, et al. Among authors: horban a. J Interferon Cytokine Res. 2018 Feb;38(2):93-100. doi: 10.1089/jir.2017.0113. J Interferon Cytokine Res. 2018. PMID: 29443655
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study.
Janczewska E, Zarębska-Michaluk D, Berak H, Piekarska A, Gietka A, Dybowska D, Mazur W, Belica-Wdowik T, Dobracki W, Tudrujek-Zdunek M, Deroń Z, Buczyńska I, Sitko M, Czauż-Andrzejuk A, Lorenc B, Białkowska-Warzecha J, Citko J, Laurans Ł, Jaroszewicz J, Socha Ł, Tronina O, Adamek B, Horban A, Halota W, Baka-Ćwierz B, Tomasiewicz K, Simon K, Garlicki A, Wawrzynowicz-Syczewska M, Flisiak R. Janczewska E, et al. Among authors: horban a. BMC Infect Dis. 2018 Nov 16;18(1):580. doi: 10.1186/s12879-018-3465-2. BMC Infect Dis. 2018. PMID: 30445916 Free PMC article.
Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study.
Piekarska A, Jabłonowska E, Garlicki A, Sitko M, Mazur W, Jaroszewicz J, Czauz-Andrzejuk A, Buczyńska I, Simon K, Lorenc B, Dybowska D, Halota W, Pawłowska M, Dobracka B, Berak H, Horban A, Tudrujek-Zdunek M, Tomasiewicz K, Janczewska E, Socha Ł, Laurans Ł, Parczewski M, Zarębska-Michaluk D, Pabjan P, Belica-Wdowik T, Baka-Ćwierz B, Deroń Z, Krygier R, Klapaczyński J, Citko J, Berkan-Kawińska A, Flisiak R. Piekarska A, et al. Among authors: horban a. AIDS Care. 2020 Jun;32(6):762-769. doi: 10.1080/09540121.2019.1645808. Epub 2019 Jul 25. AIDS Care. 2020. PMID: 31345052
362 results